ExaWizards and Daiichi Sankyo participate as core partner companies in the total care ecosystem concept. Started providing healthcare-specific data integration utilization platform products

ExaWizards Inc.
ExaWizards and Daiichi Sankyo participate as core partner companies in the total care ecosystem concept. Started providing
healthcare-specific data integration utilization platform products – Toward the Realization of Healthcare as a Service in the Medical Healthcare Field –

ExaWizards Co., Ltd. (Minato-ku, Tokyo, President: Hiroshi Ishiyama, hereinafter referred to as ExaWizards), which is working to solve social issues through services that utilize AI, is Daiichi Sankyo Co., Ltd. (Chuo-ku, Tokyo, CEO President: Jun Manabe, hereinafter referred to as Daiichi Sankyo), we are pleased to inform you that we will participate as a core partner company for the construction of the total care ecosystem platform and the realization of Healthcare as a service.
[Image 1

☑︎About Total Care Ecosystem
Daiichi Sankyo is building a new ecosystem* that aims to solve the problems of each patient and individual consumer and realize Well-Being. It is an initiative that aims to create and provide total care solutions ranging from health promotion to prevention, treatment, and prognosis care by collaborating with providers, IT companies, etc. ☑︎ Expected role of ExaWizards
ExaWizards will support various planning and design for the
realization of a total care ecosystem, develop digital health products, and develop and verify a data integration utilization platform for building a total care platform**.

Starting with the field of oncology (cancer), this initiative will develop applications for both medical professionals and patients to be used in clinical research, and will also provide wearable data using our proprietary AI platform “exaBase.” Build a prediction algorithm based on the data obtained from the app, including

In addition, in building the data integration and utilization platform for these initiatives, we will utilize the exaBase Healthcare Data Platform, a data utilization platform that ExaWizards owns and specializes in the medical and healthcare fields. In the future, together with various partner companies that will expand the lineup, we plan to expand new solutions and platform functions not only in the oncology field but also for patients and consumers.
[Image 2

☑ExaWizards Executive Officer Care & Med Tech Division Manager Yasushi Hama’s comment
The drug discovery AI business was launched as a result of joint research*** between Kyoto University and RIKEN. We have been promoting activities in the center. In addition to simple AI data analysis, model building, and AI product development, we have also supported business flow design and human resource development to create on-site results.

We are very pleased to announce that we have decided to collaborate not only in the field of drug discovery research, but also to build a total care platform ecosystem that is of high management importance toward the realization of the 2030 vision, and to realize Healthcare as a Service. increase.
In the future, our AI engineers, software engineers, UX/UI designers, BizDev and cross-sectional members of the company will work together to build platforms and build external alliances to use AI and create results for solving social issues. We will continue to promote collaboration.
* “About the start of a project to build a total care ecosystem”
https://www.daiichisankyo.co.jp/files/news/pressrelease/pdf/202212/20221219_J.pdf **Total Care Platform: An IT platform that enables data utilization by linking individual health and medical data with a common ID in the total care ecosystem.
*** “ExaWizards, an AI venture company, has successfully developed AI core technology with the aim of significantly improving the
productivity of drug discovery. Full-scale efforts toward practical application in the industrial world”
https://exawizards.com/archives/881
**** “AI venture ExaWizards launches joint development project with Daiichi Sankyo to realize data-driven drug discovery in the small molecule area” https://exawizards.com/archives/6012
☑ Held data-driven solution seminars using healthcare data
At the online seminar to be held on February 3, 2023, Daiichi Sankyo will give a presentation on the outline of the total care ecosystem, the construction of the platform, and the details and prospects of efforts to realize healthcare as a service. I will explain.

If you are interested in data-driven solutions that utilize healthcare data, please invite us and join us.
Event: “Daiichi Sankyo’s Transformation from a Drug Discovery Company to a Service Company – The Whole Picture of the Total Care Ecosystem” Date: February 3, 2023 17:00-18:00
Click here to register for the event
https://event.exawizards.com/misc/2022225?utm=source_press
Click here for Care & Med Tech business.
https://exawizards.com/care-med-tech
*exaBase is a registered trademark of ExaWizards.
[ExaWizards Co., Ltd. Company Profile]
Company name: ExaWizards Co., Ltd.
Location: Shiodome Sumitomo Building 21F, 1-9-2 Higashi-Shimbashi, Minato-ku, Tokyo
Established: February 2016
Representative: Akira Ishiyama, President and Representative Director Business description: Industrial innovation and resolution of social issues through service development utilizing AI
URL: https://exawizards.com/
[Daiichi Sankyo Company Profile]
Company name: Daiichi Sankyo Co., Ltd.
Location: 3-5-1 Nihonbashi Honcho, Chuo-ku, Tokyo
Established: September 28, 2005
Representative: Jun Manabe, President and Representative Director Business: R&D, manufacturing, sales, etc. of pharmaceuticals URL: https://www.daiichisankyo.co.jp/
Details about this release:
https://prtimes.jp/main/html/rd/p/000000146.000030192.html

MAIL:cr@prtimes.co.jp

rehow

%d bloggers like this: